The Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth

scientific article

The Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth is …
instance of (P31):
meta-analysisQ815382
systematic reviewQ1504425
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1289/EHP.1307893
P3181OpenCitations bibliographic resource ID86887
P932PMC publication ID4181929
P698PubMed publication ID24968388
P5875ResearchGate publication ID263433146

P50authorTracey J. WoodruffQ79276473
Daniel A. AxelradQ50419939
P2093author name stringKaren A Robinson
Dylan S Atchley
Erica Koustas
Juleen Lam
Patrice Sutton
Paula I Johnson
Saunak Sen
P2860cites workImmunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alphaQ23914416
Industry sponsorship and research outcomeQ24202591
The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking waterQ24623988
Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA)Q24632957
Endocrine disrupting properties of perfluorooctanoic acidQ24633469
Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growthQ24647791
Perfluorinated chemicals and fetal growth: a study within the Danish National Birth CohortQ24680484
Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birthQ24680500
Meta-analysis in clinical trialsQ27860779
Sources, fate and transport of perfluorocarboxylatesQ28293419
Environmental chemicals in pregnant women in the United States: NHANES 2003-2004Q28389338
GRADE guidelines: 3. Rating the quality of evidenceQ29547891
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliographyQ29615697
GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)Q29619791
Births: final data for 2010.Q30833846
An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciencesQ84069114
How to obtain the P value from a confidence intervalQ84579508
Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposuresQ85173906
The GRADE approach and Bradford Hill's criteria for causationQ85197280
Perfluorinated compounds in umbilical cord blood and adverse birth outcomesQ31083691
Meta-analysis of skewed data: combining results reported on log-transformed or raw scalesQ33370319
Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animalsQ34207902
The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomesQ34275302
The Navigation Guide - evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growthQ34275308
The Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth.Q34275367
The developmental toxicity of perfluoroalkyl acids and their derivativesQ34331477
The toxicology of perfluorooctanoateQ34343282
Perfluoroalkyl acids: a review of monitoring and toxicological findingsQ34630884
Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples.Q34799750
Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcomeQ34998270
Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed communityQ35874820
Environmental and toxicity effects of perfluoroalkylated substancesQ35887227
Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort studyQ35941792
Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort StudyQ36023451
Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio ValleyQ36229096
Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girlsQ36379797
Emerging endocrine disrupters: perfluoroalkylated substancesQ37100285
Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review.Q37149764
Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectivesQ37476192
GRADE guidelines: 9. Rating up the quality of evidenceQ37908614
Polyfluorinated compounds: past, present, and futureQ37922167
Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literatureQ38007735
Guest editorial: biomarkers of perfluorinated chemicals and birth weightQ42714063
Pre- and postnatal exposure to perfluorinated compounds (PFCs).Q42932834
Maternal exposure to perfluorinated acids and fetal growthQ43253111
Forest Plot Viewer: a new graphing toolQ43502632
Comparing the population neurodevelopmental burdens associated with children's exposures to environmental chemicals and other risk factorsQ43505312
Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008.Q43745356
Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefitQ45068572
Umbilical cord blood levels of perfluoroalkyl acids and polybrominated flame retardants.Q46012667
Determinants of maternal and fetal exposure and temporal trends of perfluorinated compoundsQ46198292
Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth CohortQ46442964
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesQ56528982
Trans-Placental Transfer of Thirteen Perfluorinated Compounds and Relations with Fetal Thyroid HormonesQ58765976
The effect of prenatal perfluorinated chemicals exposures on pediatric atopyQ61851028
P433issue10
P407language of work or nameEnglishQ1860
P921main subjecthydrocarbonQ43648
carboxylic acidQ134856
systematic reviewQ1504425
lipidQ11367
evidence-based medicineQ691640
maternal exposureQ67002819
physiological phenomenonQ66615932
P1104number of pages12
P304page(s)1028-1039
P577publication date2014-10-01
P1433published inEnvironmental Health PerspectivesQ1345904
P1476titleThe Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth
P478volume122

Reverse relations

cites work (P2860)
Q28554273A Systematic Review and Meta-Analysis of Multiple Airborne Pollutants and Autism Spectrum Disorder
Q92816502A Systematic Review of the Epidemiologic Literature Assessing Health Outcomes in Populations Living near Oil and Natural Gas Operations: Study Quality and Future Recommendations
Q30234472A primer on systematic reviews in toxicology.
Q28384100A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals
Q92705241Adaptation of the Systematic Review Framework to the Assessment of Toxicological Test Methods: Challenges and Lessons Learned with the Zebrafish Embryotoxicity Test
Q28384535Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan
Q45949327Association between Exposure to p,p'-DDT and Its Metabolite p,p'-DDE with Obesity: Integrated Systematic Review and Meta-Analysis.
Q51763587Association between persistent endocrine-disrupting chemicals (PBDEs, OH-PBDEs, PCBs, and PFASs) and biomarkers of inflammation and cellular aging during pregnancy and postpartum.
Q99556536Associations between prenatal maternal exposure to per- and polyfluoroalkyl substances (PFAS) and polybrominated diphenyl ethers (PBDEs) and birth outcomes among pregnant women in San Francisco
Q36350881Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK)
Q52563098Automated screening of research studies for systematic reviews using study characteristics.
Q88601254Breastfeeding as a Predictor of Serum Concentrations of Per- and Polyfluorinated Alkyl Substances in Reproductive-Aged Women and Young Children: A Rapid Systematic Review
Q94948784Challenges and recommendations on the conduct of systematic reviews of observational epidemiologic studies in environmental and occupational health
Q37077698Cross-Sectional Associations of Serum Perfluoroalkyl Acids and Thyroid Hormones in U.S. Adults: Variation According to TPOAb and Iodine Status (NHANES 2007-2008).
Q36225641Cumulative Chemical Exposures During Pregnancy and Early Development
Q33898370Cumulative effects of prenatal-exposure to exogenous chemicals and psychosocial stress on fetal growth: Systematic-review of the human and animal evidence.
Q49843499Cumulative exposure to environmental pollutants during early pregnancy and reduced fetal growth: the Project Viva cohort
Q46019996Developmental PBDE Exposure and IQ/ADHD in Childhood: A Systematic Review and Meta-analysis.
Q28383132EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
Q29247894Early Life Exposure to Endocrine Disrupting Chemicals and Childhood Obesity and Neurodevelopment
Q47789399Early Pregnancy Perfluoroalkyl Substance Plasma Concentrations and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics?
Q99623638Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects
Q93000711Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women
Q60949067Endocrine Disruptors and Autism Spectrum Disorder in Pregnancy: A Review and Evaluation of the Quality of the Epidemiological Evidence
Q62091446Endocrine disruptors and neonatal anthropometry, NICHD Fetal Growth Studies - Singletons
Q38890087Endocrine-Disrupting Chemicals and Reproductive Health.
Q89861740Endocrine-Disrupting Chemicals in Human Fetal Growth
Q91347645Environmental contaminants and child's growth
Q89779976Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX)
Q39400487Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature
Q38266411Fetal growth and maternal glomerular filtration rate: a systematic review.
Q36993990GRADE: Assessing the quality of evidence in environmental and occupational health
Q42617846Gestational exposure to endocrine disrupting chemicals in relation to infant birth weight: a Bayesian analysis of the HOME Study
Q102152315Gestational perfluoroalkyl substance exposure and body mass index trajectories over the first 12 years of life
Q42375164Hazardous waste and health impact: a systematic review of the scientific literature.
Q92531127Human zoonotic tuberculosis and livestock exposure in low- and middle-income countries: A systematic review identifying challenges in laboratory diagnosis
Q59189011Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes
Q40533182Impacts of geocoding uncertainty on reconstructed PFOA exposures and their epidemiological association with preeclampsia
Q89247444In Response: Bias in the science that supports environmental assessments--A perspective from regulatory assessment
Q50079208Incorporation of fetal and child PFOA dosimetry in the derivation of health-based toxicity values
Q36095017Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013.
Q33564787Maternal Concentrations of Perfluoroalkyl Substances and Fetal Markers of Metabolic Function and Birth Weight
Q36513368Maternal and Neonatal Levels of Perfluoroalkyl Substances in Relation to Gestational Weight Gain
Q38667467Maternal serum PFOA concentration and DNA methylation in cord blood: A pilot study
Q64125808Maternal serum concentrations of perfluoroalkyl substances and birth size in British boys
Q91961959Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight
Q92949725Metabolomics of childhood exposure to perfluoroalkyl substances: a cross-sectional study
Q42352810O'Connor et al. systematic review regarding animal feeding operations and public health: critical flaws may compromise conclusions
Q50130740Obesity Pathogenesis: An Endocrine Society Scientific Statement
Q100444139Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
Q40137662Perfluoroalkyl Substances during Pregnancy and Offspring Weight and Adiposity at Birth: Examining Mediation by Maternal Fasting Glucose in the Healthy Start Study
Q92714774Perfluorooctanoic acid exposure during pregnancy alters the apoptosis of uterine cells in pregnant mice
Q92154674Perturbation of Nuclear Hormone Receptors by Endocrine Disrupting Chemicals: Mechanisms and Pathological Consequences of Exposure
Q38690520Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations
Q47732834Potential Developmental and Reproductive Impacts of Triclocarban: A Scoping Review
Q97526919Pregnancy-induced changes in serum concentrations of perfluoroalkyl substances and the influence of kidney function
Q57144626Prenatal Exposure to Perfluoroalkyl Substances: Infant Birth Weight and Early Life Growth
Q64136246Prenatal exposure to perfluoroalkyl substances and adipocytokines: the HOME Study
Q36396103Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: The HOME study
Q93160224Reducing exposure to high levels of perfluorinated compounds in drinking water improves reproductive outcomes: evidence from an intervention in Minnesota
Q57846605Response of chlorophyll a to total nitrogen and total phosphorus concentrations in lotic ecosystems: a systematic review protocol
Q38690032Systematic comparison of study quality criteria
Q42924301Systematic reviews: perhaps "the answer to policy makers' prayers"?
Q60924352Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study
Q37580534The Association of Prenatal Exposure to Perfluorinated Chemicals with Glucocorticoid and Androgenic Hormones in Cord Blood Samples: The Hokkaido Study
Q37041883The Emergence of Systematic Review in Toxicology
Q34275367The Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth.
Q34275308The Navigation Guide - evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth
Q34275302The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes
Q42924277The Navigation Guide: systematic review for the environmental health sciences
Q99575838The effect of occupational exposure to welding fumes on trachea, bronchus and lung cancer: A protocol for a systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury
Q28079859Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals
Q36601073Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population
Q77796922WHO/ILO work-related burden of disease and injury: protocol for systematic reviews of exposure to occupational ergonomic risk factors and of the effect of exposure to occupational ergonomic risk factors on osteoarthritis of hip or knee and ...